Effectiveness Analysis of Natalizumab versus Fingolimod using Patient-Reported Outcomes in Patients with Multiple Sclerosis
Primary Objective
The purpose of this study is to compare two medications, natalizumab and fingolimod, used in the treatment of multiple sclerosis (MS) through a variety of previously validated patient reported outcomes (PROs).
This Study is
No Longer Enrolling
Details
Age
Child to Adult
Phase
Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.
Type of Study
Observational
Locations
University of Colorado Hospital
Study ID
Protocol Number: 13-2767
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers